Get started
Author

Silvia Bessi

HER2-Positive Circulating Tumor Cells in Breast Cancer
2011 · Michail Ignatiadis, Françoise Rothé, et al. · PLoS ONE · 203
PDF
Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients
2009 · Marta Pestrin, Silvia Bessi, et al. · Breast Cancer Research and Treatment · 201
Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study
2012 · Marta Pestrin, Silvia Bessi, et al. · Breast Cancer Research and Treatment · 110
Recent advances in systemic therapy. New diagnostics and biological predictors of outcome in early breast cancer
2009 · Catherine Oakman, Silvia Bessi, et al. · Breast Cancer Research · 77
PDF
International study on inter-reader variability for circulating tumor cells in breast cancer
2014 · Michail Ignatiadis, Sabine Riethdorf, et al. · Breast Cancer Research · 58
PDF
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells
2013 · V Barbetti, A Morandi, et al. · Oncogene · 33
PDF
New strategies to identify molecular markers predicting chemotherapy activity and toxicity in breast cancer
2007 · A. Di Leo, W. Claudino, et al. · Annals of Oncology · 27
Inter- and intra-tumoral heterogeneity in DNA damage evaluated by comet assay in early breast cancer patients
2012 · Francesca Galardi, Catherine Oakman, et al. · The Breast · 15
PDF
New diagnostics and biological predictors of outcome in early breast cancer
2009 · Catherine Oakman, Silvia Bessi, et al. · 12
Significance of Micrometastases: Circulating Tumor Cells and Disseminated Tumor Cells in Early Breast Cancer
2010 · Catherine Oakman, Marta Pestrin, et al. · Cancers · 11
PDF
Part II – Analytical phase
2025 · Elena Guerini-Rocco, Simonetta Buglioni, et al. · Pathologica · 6
PDF
An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples
2023 · Paolo Bironzo, Francesco Pepe, et al. · Diagnostics · 6
PDF
Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study
2022 · Silvia Bessi, Francesco Pepe, et al. · Journal of Clinical Pathology · 5
Comparison between two different next generation sequencing platforms for clinical relevant gene mutation test in solid tumours
2020 · Silvia Bessi, Francesco Pepe, et al. · Journal of Clinical Pathology · 2
Molecular Analysis of Single Circulating Tumor Cells (CTCS) Isolated from Metastatic Breast Cancer (MBC) Patients (PTS)
2013 · M. Pestrin, F. Galardi, et al. · Annals of Oncology · 2
Erbb2 Variants Distribution in Non-small Cell Lung Cancer: an Italian Real-world Experience
2023 · S. Bessi, U. Malapelle, et al. · Annals of Research in Oncology · 1
PDF
Harmonization trial of FGFR1-3 testing strategies in cholangiocarcinoma patients: an Italian multicenter experience
2025 · Francesco Pepe, Gianluca Russo, et al. · Pathologica
PDF
90P Identification in Breast Cancer Cells of A Novel Mechanism of Csf-1R Signaling Which Involves its Nuclear Translocation and Binding to the Promoter of Genes Relevant to Cancer Progression
2012 · E. Rovida, V. Barbetti, et al. · Annals of Oncology
PDF
37P HER2 Tumor Heterogeneity and Discrepancies in HER2 Status Between Primary Tumor and Corresponding Circulating Tumor Cells in Metastatic Breast Cancer Patients
2012 · I. Migliaccio, F. Galardi, et al. · Annals of Oncology
PDF
P4-07-14: Circulating Tumor Cells (CTCs) Detection and HER2 Profiling by CellSearch® in Non-Metastatic Breast Cancer: An International Ring Study To Assess Inter-Reader Variability.
2011 · M Ignatiadis, J-Y Pierga, et al. · Cancer Research
Circulating Tumor Cells (CTCs) Detection and HER2 Profiling by CellSearch® in Non-Metastatic Breast Cancer: An International Ring Study To Assess Inter-Reader Variability
2011 · Michail Ignatiadis, Jean‐Yves Pierga, et al. · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)
HER2 status correlation between Circulating Tumor Cells (CTC) and corresponding primary tumor in advanced breast cancer patients (pts)
2008 · M. Pestrin, S. Bessi, et al. · European Journal of Cancer Supplements
Morphological and molecular analysis of Circulating Tumor Cells (CTCs) in breast cancer: a real possibility
2008 · S. Bessi, M. Pestrin, et al. · European Journal of Cancer Supplements
Works count: 25
Citation count: 769
H-index: 10
I10-index: 10
Year
Topic
Type